Genetic disruption of calcineurin improves skeletal muscle pathology and cardiac disease in a mouse model of limb-girdle muscular dystrophy.
about
Deregulated protein kinase A signaling and myospryn expression in muscular dystrophyImpaired contractile function and calcium handling in hearts of cardiac-specific calcineurin b1-deficient miceGenetic modifier screens reveal new components that interact with the Drosophila dystroglycan-dystrophin complex.Therapeutic targeting of signaling pathways in muscular dystrophy.Absence of γ-sarcoglycan alters the response of p70S6 kinase to mechanical perturbation in murine skeletal muscle.Genome-wide screening for genes associated with FK506 sensitivity in fission yeastIdentification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy.Wasting mechanisms in muscular dystrophy.Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient miceSickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology.Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function.The functional role of calcineurin in hypertrophy, regeneration, and disorders of skeletal muscle.Dexamethasone induces dysferlin in myoblasts and enhances their myogenic differentiation.A naturally occurring calcineurin variant inhibits FoxO activity and enhances skeletal muscle regeneration.Overexpression of SERCA1a in the mdx diaphragm reduces susceptibility to contraction-induced damage.Elucidating the Candida albicans calcineurin signaling cascade controlling stress response and virulence.Cyclosporin A Promotes in vivo Myogenic Response in Collagen VI-Deficient Myopathic Mice.Stimulation of calcineurin Aalpha activity attenuates muscle pathophysiology in mdx dystrophic mice.
P2860
Q28506118-54AF6D27-79B0-4256-A25F-362B9E66FD38Q30491332-1E702438-337B-4D6C-A48A-FDEE131EE3E1Q33342805-45CE7CD7-2EBC-452B-92C4-01771ADC420FQ33707964-AF2F9066-4A47-4238-B89C-6BA5A332CF9EQ33893451-C6AE9D2B-7171-4835-8CDD-2A79724A9AFFQ33995703-13D688EA-910B-45F3-B773-E6A143C684E1Q37010722-D000A225-2733-470E-A8B0-9282177C8162Q37138490-01959884-BC58-4319-A90F-D641C5AC70DBQ37257159-FCC12ADF-DE7F-474A-8755-B87A1D884950Q37258558-47A5E94F-7E7B-4BBC-92DC-9D75AD28FB00Q37497985-2A02F5CB-A7F6-414C-B6E4-619A2A413672Q37727810-D0885A87-2FA6-4B69-A03E-7A72C0AF41FBQ39751162-166D152F-E627-4C71-A86B-B7DB205EADC2Q40034287-65C09E89-5BAA-4D9B-9E88-E50A260E8E05Q41118342-506522B7-4011-4BE6-8275-3C01A1E00777Q42020716-91778B41-064F-454B-8099-D0DBF783EDE3Q42069294-78FFE934-73D9-44BA-846E-A55CF7A0B7FDQ46805060-60EF88CF-CB67-49F8-BCB9-C965D2DC6299
P2860
Genetic disruption of calcineurin improves skeletal muscle pathology and cardiac disease in a mouse model of limb-girdle muscular dystrophy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 February 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic disruption of calcineu ...... imb-girdle muscular dystrophy.
@en
Genetic disruption of calcineu ...... imb-girdle muscular dystrophy.
@nl
type
label
Genetic disruption of calcineu ...... imb-girdle muscular dystrophy.
@en
Genetic disruption of calcineu ...... imb-girdle muscular dystrophy.
@nl
prefLabel
Genetic disruption of calcineu ...... imb-girdle muscular dystrophy.
@en
Genetic disruption of calcineu ...... imb-girdle muscular dystrophy.
@nl
P2093
P2860
P356
P1476
Genetic disruption of calcineu ...... imb-girdle muscular dystrophy.
@en
P2093
Douglas P Millay
Elizabeth M McNally
Francisco J Naya
H Lee Sweeney
Michelle A Sargent
Stephanie A Parsons
P2860
P304
10068-10078
P356
10.1074/JBC.M609368200
P407
P577
2007-02-07T00:00:00Z